Becker’s Clinical Leadership recently featured Axuall following an interview with Dr. Chad Smith, physician executive and former chief medical officer at Mercy Hospital, Oklahoma City. The article highlights how Mercy partnered with Axuall, Microsoft, and Mayo Clinic to create a unified, validated provider data set. This collaboration has significantly improved the speed and accuracy of data collection, allowing Mercy to overhaul its physician onboarding process — reducing onboarding time from 120–140 days to as low as 90 days by automating manual steps with Axuall’s AI-powered technology.
“Once we get that data, it’s much more accurate. We’re having to spend less time and resources on scrubbing the data, reworking the data, and we’re now able to parlay that into completely revamping our onboarding process.” — Dr. Chad Smith, Physician Executive
Click here to read the full article by Paige Twenter in Becker’s Clinical Leadership.
We’re excited to have our Co-Founder and CEO, Charlie Lougheed’s insights included in Hit Consultant’s 24 Executive Healthcare AI Predictions & Trends to Watch in 2025.
“The AI naysayers of 2024 will be proven wrong. We’re already seeing AI make meaningful strides in reducing documentation workload for healthcare providers. Meanwhile, reducing administrative costs through AI-enabled automation will continue to gain momentum, especially given the lower risk and regulatory burden compared to clinical decision support use cases. While healthcare has always moved slower than other industries, it has hit a capacity limit in costs and resources that will demand additional incorporation from AI technologies.”
Click here to read the complete list of 2025 AI predictions and trends from fellow industry leaders!
We’re thrilled to see our Chief Growth Officer, Zachary Phillips, featured in MedCity News with insights on how to ‘Prioritize Provider Data for Seamless M&A Success.’
“When it comes to mergers and acquisitions (M&As), they tend to mesh in one of two ways: Oil and water or peanut butter and jelly. When organizing the merger of health systems, more mesh equals less mess. However, M&As can be incredibly complex, with cultural, workflow, financial, and technological factors coming into play. There’s a lot more that goes into determining if an M&A makes sense beyond an agreed-upon price. Will it improve care for patients? Will more patients have better access to care? Will it drive more revenue? These are just a few of the questions that are considered ad nauseam before a CEO signs on the dotted line.
Amid these complexities, one crucial element often gets overlooked — provider data. Health systems preparing for an M&A, or even those not immediately considering one, must prioritize a robust workforce data strategy. This approach is essential for navigating today’s increasingly frequent healthcare consolidations. A recent Kaufman Hall report reveals that healthcare M&As are at a seven-year high, making now the time to assess and refine how provider data is managed.”
Learn more about why prioritizing provider data is key to seamless M&A success by reading the full article here.
We’re excited to have our Co-Founder and CEO, Charlie Lougheed’s insights included in Healthcare IT Today’s Healthcare Staffing Shortage and Burnout predictions for 2025!
“The healthcare industry is bracing for significant staffing challenges as we approach 2025, with predictions indicating significant shortages across various roles and license types. In 2025, McKinsey projects the United States will face a critical shortage of 200,000 to 450,000 nurses available for direct patient care, representing a 10% to 20% shortage in the nursing workforce needed to meet patient demand. Similarly, the physician workforce will experience a deficit of 38,000 to 120,000 physicians by 2034. As demand outpaces what medical schools, nursing programs, and other programs can churn out, the healthcare sector must undergo significant changes to address these challenges and adopt new strategies.
There’s an increasing focus on technological integration, with a growing demand for professionals skilled in AI, data science, and robotics. Healthcare organizations also implement flexible work arrangements, including remote and hybrid models, particularly for administrative and support roles. In 2025, healthcare institutions will prioritize workforce sustainability by implementing technologies that enable them to innovate recruitment, onboarding, care team alignment, and retention strategies. Big data and AI will play an increasing role in this.”
Click here to read the complete list of 2025 predictions from fellow industry leaders!
Cleveland, OH – December 23, 2024—Axuall is excited to announce a new partnership with HealthStream® that will provide clinicians and medical staff personnel with an integrated solution that makes the credentialing process more efficient and accurate.
Through this partnership, Axuall will now connect to HealthStream’s hStream ecosystem. Specifically, HealthStream’s CredentialStream customers will gain access to Axuall’s Clinician Wallet, a secure, vendor-agnostic platform where clinicians can store all their credentialing information in one centralized place. This digital wallet eliminates the hassle of managing multiple accounts and platforms, giving clinicians more time to focus on patient care.
In today’s fast-paced healthcare landscape, maximizing provider efficiency is crucial—not only for patient care but also for organizational revenue. With each provider generating an average of $2.38 million in net revenue annually, or more than $6,000 daily, on behalf of their affiliated hospitals, streamlining patient appointments is more essential than ever. Traditional credentialing methods can be time-consuming, often taking clinicians weeks or months to complete. This presents a substantial opportunity for medical staff professionals to provide value by making this process more efficient.
Streamlined Experience for Medical Staff Professionals
Multiple customers are already experiencing the advantage of Axuall’s integration with CredentialStream. Using this new accelerated option in clinician onboarding, CredentialStream customers have reported up to a 70% reduction in the time it takes to process applications. This significant improvement is made possible by leveraging Axuall’s Clinician Data Network through its digital wallet.
Axuall’s Clinician Wallet pre-fills verified information, reducing clinicians’ time to input and validate data. This process alleviates administrative burdens for healthcare professionals and allows organizations to quickly onboard new talent, enhancing operational efficiency and patient care delivery.
Furthermore, as the exchange between the medical staff office and clinicians is reduced, the time to verify credentials is also reduced. In contrast, the time it takes to get clinicians to committee approvals speeds up. All of these factors move clinicians into patient care settings faster.
“The hStream platform continues to grow, delivering even greater value for our customers. By connecting pre-validated information sources like Axuall’s Clinician Wallet to hStream, CredentialStream users now have more powerful options to streamline workflows. Our expanding ecosystem ensures clients benefit from seamless integrations and unparalleled efficiency,” said Michael Sousa, President of HealthStream Credentialing.
Strengthening the Partnership Through Integration
HealthStream and Axuall are not just maintaining but continuing to invest in enhancing their collaborative efforts. This ongoing investment underscores a shared commitment to improve the credentialing landscape for all stakeholders.
“With healthcare organizations’ most important asset being their staff, it is critical that we make the credentialing process for clinicians and medical staff as frictionless as possible,” said Charlie Lougheed, CEO of Axuall. “We are always looking for ways to make it easier and faster by developing new features for CredentialStream customers.”
Integrating Axuall’s innovative technologies with the HealthStream platform and integrations marketplace marks a significant advancement in clinician credentialing. Together, they are setting new standards for efficiency, accuracy, and user experience in the healthcare industry.
About CredentialStream: The Leading Credentialing, Privileging and Provider Enrollment solution
CredentialStream serves as the source of truth for 800 customers and over 50 top health systems across the United States, offering a highly configurable solution that meets the needs of modern healthcare organizations and ensuring that all provider data is accurate, up-to-date, and easily accessible.cant time in the credentialing process and begin generating revenue much quicker.
Ready to Transform Your Credentialing Process?
See how the integration of HealthStream’s CredentialStream with Axuall’s Clinician Wallet can streamline your workflows and accelerate onboarding.Schedule a Demotoday to take the next step in efficient clinician onboarding.
About Axuall
Built with leading healthcare systems, Axuall is a workforce intelligence company powered by a national real-time practitioner data network. The technology enables healthcare systems, staffing firms, telehealth, and health plans to dramatically reduce onboarding and enrollment time while providing robust data insights for network planning, analytics, and reporting. To learn more, visit www.axuall.com or follow Axuall on LinkedIn.
Cleveland, OH – October 31, 2024—Axuall, the leader in clinical workforce intelligence, is proud to announce new relationships with three organizations – Inova Health System, Community Health Network, and PayrHealth. These healthcare organizations are collaborating with Axuall to further transform recruiting, optimizing, and planning of their clinician workforces. By accessing Axuall’s Clinician Data Network, which consists of 19,000 primary sources and 19 billion claims representing 1.1 million physicians nationwide, organizations can onboard clinicians over 15 days faster than traditional methods. This significantly enhances operating margins and ensures adequate staffing at care sites.
Each partner will integrate products from Axuall’s suite of solutions, including:
Axuall Confirm: An intelligent data network that streamlines the submission and verification of clinician applications through a clinician-friendly wallet, cutting processing time by as much as 70%
Axuall Explore: A national search engine that enables precision clinician identification, qualification, engagement, and onboarding for healthcare recruitment efforts while providing the tools and data for robust analysis of healthcare providers, facilities, and markets for strategic workforce planning.
Here’s how the solutions will improve the workforce management of each organization:
Inova Health System
The Northern Virginia health system selected Axuall’s Confirm and Explore solutions for its staff of over 5,000 clinicians, which provides access to timely data that can be directly incorporated into its credentialing and privileging software. When hiring future clinicians, recruiters will have insights into Axuall’s clinician phenotypes consisting of a clinician’s care settings, employment types, clinical focus, and practice status, enabling them to conduct precision searches and pursue the most qualified candidates.
Community Health Network
Axuall Confirm will streamline the onboarding process and provide continuous data monitoring for more than 2,500 clinicians in the Community Health Network system. Access to Axuall’s data network will allow the Indiana healthcare system to onboard staff more quickly and with less risk.
PayrHealth
The leading Payor Relationship Management solution that helps providers negotiate contracts and reimbursements, optimize billing, and streamline credentialing, will now use Axuall Confirm to provide credentialing services for its network of provider customers.
Charlie Lougheed, the CEO and founder of Axuall, says the partnerships will significantly improve working conditions in healthcare.
“Clinician data can address so many large-scale, difficult-to-tackle issues in healthcare, like workforce shortages and burnout,” he said. “Within Axuall’s Workforce Intelligence Network, our partners have access to a data set representing over a million practicing physicians, providing them with the necessary insights to hire strategically and plan methodically, ensuring they’re equipped to provide a better working environment.”
With nearly 20,000 new clinicians benefiting from Axuall’s partnerships over the past several months, health systems have an exciting opportunity to save significant time in the credentialing process and begin generating revenue much quicker.
About Axuall
Built with leading healthcare systems, Axuall is a workforce intelligence company powered by a national real-time practitioner data network. The technology enables healthcare systems, staffing firms, telehealth, and health plans to dramatically reduce onboarding and enrollment time while providing robust data insights for network planning, analytics, and reporting. To learn more, visit www.axuall.com or follow Axuall on LinkedIn.
8 digital health and life sciences executives share their hot takes and insights from the recent annual JPM Healthcare Conference 2024
Virgil Bretz, co-founder and CEO of MacroHealth
“The annual JP Morgan Healthcare Conference is still one of the most efficient ways to meet with capital partners. Other conferences are increasingly attracting the investment community, such as HLTH, but none are as concentrated as JP Morgan. This conference is unusual in that meetings for small and middle market companies typically don’t take place within the official conference but are instead scattered all over the surrounding hotels and restaurants. It can be impossible to find an unoccupied space or even a table to meet and present, but despite this it remains the preeminent event for executives looking to meet with investors.
One takeaway I had from the event is the sense that capital markets are more optimistic this year. People I spoke with were more positive about the economic climate, with an underlying sentiment that there is still significant portfolio cleanup to do with companies that may have been aggressively funded during the heights of the market. There is a lot of capital out there right now and quality companies will have no problem securing it, but those that are marginal, or underperforming might continue to have a tough time getting funded.”
Charlie Lougheed, CEO of Axuall, Inc.
“The twenty-twenties have not been kind to healthcare systems. During the last two JPMorgan Healthcare Conferences, health system leaders’ mood was determined yet glum — the pandemic, workforce shortages, burnout, stagnant reimbursement, and depleting budgets were all top of mind. However, while challenges remain, optimism at this year’s event was palpable as the tools and data to mitigate future risks and optimize workforces became available. A movement toward workforce intelligence that proactively addresses an increasingly complex supply and demand dynamic is clearly underway — signaling additional promise for a sector recovering from a painful few years.”
“The biggest challenge for chronic condition management solutions in a growing, saturated enterprise space is consumer awareness. With the reach Omada has with enterprises, partnering with Amazon opens up doors in terms of distribution and letting consumers know that Omada is a benefit they have access to — at massive scale.”
“Metabolic health, weight loss, and obesity are at the center of it all, with GLPs generating the most buzz. Everyone is concerned about adherence and stickiness of the drugs and early data shows that without the appropriate programs, people drop off and gain back all they lost. LillyDirect, more precisely, Big Pharma starting to play the direct-to-consumer game, is getting a lot of attention. There’s a huge opportunity for partnerships between innovative tech startups that are consumer-focused and big pharma that’s focused on R&D and commercialization, of course, with the supervision of doctors. Another popular topic is the pipeline of clinical trials focused on additional benefits of GLPs beyond obesity, diabetes, and weight loss. Several waves are expected around multiple areas of benefits like heart conditions, addiction, and more. And lastly, but definitely not least, Al is huge – every major CEO presentation is focused on it.”
Anu Sharma, CEO and Co-Founder of Millie Clinic
“Women’s health was everywhere at JPM — the mainstage, IPO chatter, sold-out side events, and even news headlines lamenting the lack of spaces to pump milk. The healthcare investing universe is finally catching up to the fact that women are the power users of the healthcare system accounting for 51% of the population and 80% of care decisions.”
M&A: The Catalyst for Success in the Pharmaceutical Landscape
Embracing M&A in the pharmaceutical industry has become a powerful strategy to unlock innovation and growth, especially in the face of looming patent cliffs. Front and center at the JPM 2024 Healthcare Conference, M&A activities are fueling the industry’s potential to bring groundbreaking late-stage assets to the market. M&A makes it possible for the best data to rise, enabling rapid advancements in patient care and lucrative returns for shareholders, ultimately benefiting all stakeholders involved.
AI: The Non-Negotiable Ingredient for Pharma’s Survival and Success
The value of incorporating AI into drug discovery and development cannot be overstated. As discussions at the JPM 2024 Conference highlighted, AI adoption is non-negotiable to remain competitive in the rapidly evolving pharmaceutical landscape. By embracing the power of AI and harnessing its insights, the industry has the potential to make targeted breakthroughs, speed up development processes, and ultimately, save countless lives by fast-tracking life-saving treatments to the market.
Putting Patients First: The Core Principle That Transcends Geopolitical Challenges
Addressing the complex interplay of geopolitical risks and global drug supply chains, the JPM 2024 Conference showcased how the pharmaceutical industry must always prioritize patients’ welfare. The industry has a moral obligation to navigate geopolitical minefields and foster resilient, responsive supply chain management that ensures patients remain at the center of decision-making processes, regardless of political tensions that may arise. Given the rising geopolitical risks in 2024, all companies will have to be vigilant as to how these changes impact everything from raw materials to drug product, and ultimately patient mobility.
GLP-1 Antagonists: A Stepping Stone, Not the Ultimate Panacea, in Longevity Research
The promise of GLP-1 antagonists and similar obesity drugs highlighted at the JPM 2024 Healthcare Conference marks a significant leap forward in the fight against obesity and obesity-related diseases. However, it’s important to recognize that these treatments represent only one piece of the longevity puzzle. The industry must remain vigilant about not crowning GLP-1 antagonists as the ultimate solution. Instead, it must continuously invest in developing comprehensive therapies and tackling the complex interplay of factors that contribute to obesity and aging, ultimately pushing the boundaries of human health and longevity with an initial focus on lean mass retention during treatment.
Green Money Shoots – The financial situation for hospitals is improving, and most think this will continue over the next year. volumes are also improving.
Labor remains a core issue — in fact, every single nonprofit hospital system is still talking about the challenges associated with labor and rising labor-related costs
Automating repetitive work in healthcare will be a major trend in 2024 and key to solving some of our largest issues within the system
“Expect the current market down-cycle to largely be over by mid-year, however, investors will likely maintain a first-principles approach for some time to come. QuantHealth’s in-silico evidence-generation approach can be an invaluable tool for investors to make calculated asset assessments before deploying capital.
Due to cash reserves drying up, many early-stage biotechs will be forced to demonstrate near-term inflection points in their programs, and many will not make it to their next round. QuantHealth can be a strong biotech partner to demonstrate proof-of-concept viability for prospective investors and big-pharma partners.
With the IRA reducing the exclusivity period for many drugs, QuantHealth’s synthetic trials can be an important tool to extend a drug’s label into new indications and to support payor negotiations.
This year will mark a turning point in the integration of biological and clinical data to support end-to-end drug development, as noted by the Caris-ConcertAI and Caris-Flatiron partnerships. QuantHealth’s in-silico platform natively integrates these two knowledge domains into a single learning framework and will be a catalyst for such data integrations and partnerships.”
